Home/Filings/4/0001225208-18-005102
4//SEC Filing

LUND-JURGENSEN KIRSTEN 4

Accession 0001225208-18-005102

CIK 0000078003other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 3:44 PM ET

Size

10.1 KB

Accession

0001225208-18-005102

Insider Transaction Report

Form 4
Period: 2018-02-28
LUND-JURGENSEN KIRSTEN
Executive Vice President
Transactions
  • Tax Payment

    Common Stock

    2018-02-28$35.70/sh11,699$417,65425,529 total
  • Tax Payment

    Common Stock

    2018-02-28$36.31/sh2,573$93,42637,228 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2018-02-2819,2730 total
    Exercise: $27.37From: 2018-02-28Exp: 2018-02-28Common Stock (19,273 underlying)
  • Exercise/Conversion

    Common Stock

    2018-02-28$27.37/sh+19,273$527,50239,801 total
Footnotes (4)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001693493

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 3:44 PM ET
Size
10.1 KB